Flash Radiation Therapy
It is imperative that the radiation oncology professional remain current in the state-of-the-art techniques. The rapidly changing field of radiation oncology makes it impractical for practicing clinicians who aren’t receiving continuing education to keep up with the latest clinical trials and publications. FLASH therapy is a non-invasive treatment using an external beam delivered in high doses, at ultra-high speeds (<1 second), over 1-3 sessions. This new therapy represents an exciting and potentially promising new direction in the treatment of cancer. Clinical implementation of FLASH using scanning proton beams requires multiple treatment planning considerations: dosimetric, temporal, and spatial parameters.
The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Upon completion of this live activity, attendees should be able to do the following:
1. Describe and implement the latest flash radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice.
2. Utilize the latest flash radiation technology applications to improve patient care.
Billy Loo, Jr. MD, PhD is employed by Stanford University and receives compensation/remuneration/funding from Varian Medical Systems and has stock in TibaRay, Inc.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 0.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 Certificate of AttendanceThis activity was designated for 0.50 AMA PRA Category 1 Credit™.